Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare arsenic President Trump and others suggest unproven links betwixt the symptom reliever and autism.